Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Ipecac exemption from OTC alcohol limits

This article was originally published in The Tan Sheet

Executive Summary

Ipecac exemption from OTC alcohol limits: FDA proposes to amend regs for oral OTCs containing alcohol as an inactive ingredient by exempting ipecac syrup from the maximum concentration limits of .5% alcohol or less when used by children under six. Even if a child swallowed the entire contents of a 30 ml container of ipecac, "the ingested amount of alcohol (.75 ml) is insignificant," the agency said, and the alcohol and syrup usually are vomited along with the other stomach contents. "The benefit of ipecac syrup as an emetic outweighs any risk of adverse effects from ingestion of .75 ml of alcohol," the agency concludes. The notice of proposed rulemaking appears in the May 10 Federal Register. Written comments are due June 10...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel